InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by SANTINI GINO, Director. Officer active across 4 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 16 disclosures have been logged. History available since 20 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations16 total
9,791 shares0Common StockSEC:0001062993-25-009805:0
7,693 shares0Common StockSEC:0001062993-24-010543:0
23,645 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117106:0
100,959 shares@ US$116.5094.6% of flowOrdinary SharesSEC:0001209191-23-052367:0
23,092 shares@ US$15.232.8% of flowOrdinary SharesSEC:0001209191-23-051236:0
20,000 shares@ US$15.962.5% of flowOrdinary SharesSEC:0001209191-23-050519:0
8,111 shares0Common StockSEC:0001104659-23-064842:0
9,792 shares0Common StockSEC:0001062993-23-011814:0
3,913 sharesOrdinary SharesSEC:0001209191-23-026759:0
7,737 shares0Common StockSEC:0001104659-22-065911:0
14,035 shares0Common StockSEC:0001062993-22-013309:0
4,223 sharesOrdinary SharesSEC:0001209191-22-026458:0
7,029 shares0Common StockSEC:0001104659-21-075221
7,029 shares0Common StockSEC:0001104659-21-075221:0
9,941 shares0Common StockSEC:0001192482-21-000455
9,941 shares0Common StockSEC:0001192482-21-000455:0
16 of 16 declarations
About SANTINI GINO
Gino Santini is a board member at Collegium Pharmaceutical, Inc. and Intercept Pharmaceuticals, Inc. In this role, he contributes to the governance of the company, providing his expertise to guide strategic decisions.
